Retrospective analysis of clinical outcome of benign and malignant salavary gland tumors

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00027578

Enrollment

200

Registered

2022-01-13

Start date

2016-11-06

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

D37.0 C07 C06.9 C08.9

Interventions

Group 1: Divided according to entity and surgical site, 1. perioperative complications (e.g. nerve injuries), 2. relapse-free and 3. overall survival are recorded

Eligibility

Sex/Gender

All

Age

18 Years to 120 Years

Inclusion criteria

Inclusion criteria: Primarily surgically treated patients with benign and malignant salivary gland tumors, initial diagnosis 01/01/2000 - 31/12/2015

Exclusion criteria

Exclusion criteria: Other tumor entities (e.g., squamous cell carcinoma of the oral mucosa); Patients treated primarily with radio (chemo) therapy, primary tumor with operation alio loco.

Design outcomes

Secondary

Measure	Time frame
Occurrence of facial palsy. Occurrence of secondary tumors.	—

Primary

Measure	Time frame
Occurrence of recurrence or secondary metastasis after surgical treatment of the tumor.	—

Countries

Germany

Contacts

Public ContactMichael Ermer

Uniklinik Freiburg Klinik für MKG Chirurgie

michael.ermer@uniklinik-freiburg.de076127047010

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026